CS228506B2 - Method for the production of optical active ester of 1,4-dihydropyridincarboxyl acid - Google Patents

Method for the production of optical active ester of 1,4-dihydropyridincarboxyl acid Download PDF

Info

Publication number
CS228506B2
CS228506B2 CS805915A CS591580A CS228506B2 CS 228506 B2 CS228506 B2 CS 228506B2 CS 805915 A CS805915 A CS 805915A CS 591580 A CS591580 A CS 591580A CS 228506 B2 CS228506 B2 CS 228506B2
Authority
CS
Czechoslovakia
Prior art keywords
group
dimethyl
ester
dihydro
pyridine
Prior art date
Application number
CS805915A
Other languages
Czech (cs)
English (en)
Inventor
Egbert Wehinger
Horst Meyer
Friedrich Bossert
Robertson Towart
Kurt Stoepel
Stanislav Kazda
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of CS228506B2 publication Critical patent/CS228506B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
CS805915A 1979-09-01 1980-08-29 Method for the production of optical active ester of 1,4-dihydropyridincarboxyl acid CS228506B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2935451A DE2935451A1 (de) 1979-09-01 1979-09-01 Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel

Publications (1)

Publication Number Publication Date
CS228506B2 true CS228506B2 (en) 1984-05-14

Family

ID=6079874

Family Applications (1)

Application Number Title Priority Date Filing Date
CS805915A CS228506B2 (en) 1979-09-01 1980-08-29 Method for the production of optical active ester of 1,4-dihydropyridincarboxyl acid

Country Status (25)

Country Link
US (3) US4510310A (ja)
EP (1) EP0026317B1 (ja)
JP (2) JPS5636455A (ja)
AR (1) AR228576A1 (ja)
AT (1) ATE16101T1 (ja)
AU (1) AU545023B2 (ja)
CA (1) CA1142937A (ja)
CS (1) CS228506B2 (ja)
DD (1) DD154014A5 (ja)
DE (2) DE2935451A1 (ja)
DK (2) DK160549C (ja)
EG (1) EG15011A (ja)
ES (1) ES8104228A1 (ja)
FI (1) FI78686C (ja)
GR (1) GR70080B (ja)
HU (1) HU184821B (ja)
IE (1) IE50504B1 (ja)
IL (1) IL60937A (ja)
NO (1) NO159928C (ja)
NZ (1) NZ194805A (ja)
PH (3) PH19749A (ja)
PL (1) PL128310B1 (ja)
PT (1) PT71724B (ja)
SU (1) SU932988A3 (ja)
ZA (1) ZA805372B (ja)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2935451A1 (de) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel
JPS57200364A (en) * 1981-06-04 1982-12-08 Yoshitomi Pharmaceut Ind Ltd 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its salt
JPS57200386A (en) * 1981-06-04 1982-12-08 Yoshitomi Pharmaceut Ind Ltd Novel 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its salts
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
GB2111978B (en) * 1981-10-19 1985-05-01 Maruko Pharmaceutical Co 1 4-dihydropyridine compounds
EP0096299B1 (en) * 1982-06-03 1989-02-01 Pierrel S.p.A. Hydroxyimino and alkoxyimino derivatives of 1,4-dihydropyridine, process for the preparation thereof and pharmaceutical composition therefrom
JPS59225162A (ja) * 1983-06-03 1984-12-18 Kyowa Hakko Kogyo Co Ltd １，４−ジヒドロピリジン誘導体
JPS5970667A (ja) * 1982-10-15 1984-04-21 Kyowa Hakko Kogyo Co Ltd １，４−ジヒドロピリジン誘導体
DE3248548A1 (de) * 1982-12-29 1984-07-05 Heinrich Mack Nachf., 7918 Illertissen Acylderivate von 1,4:3,6-dianhydro-hexiten, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
JPS60120861A (ja) * 1983-12-02 1985-06-28 Otsuka Pharmaceut Co Ltd ジヒドロピリジン誘導体
DE4342196A1 (de) * 1993-12-10 1995-06-14 Bayer Ag Neue 4-Phenyl-substituierte 1,4-Dihydropyridine
IE57810B1 (en) * 1984-03-27 1993-04-21 Delagrange Lab 1,4-dihydropyridine derivatives,their preparation and their use
US5364872A (en) * 1984-04-16 1994-11-15 Yamanouchi Pharmaceutical Co., Ltd. Dihydropyridine-3,5-dicarboxylic acid ester derivatives
JPS60246313A (ja) * 1984-05-22 1985-12-06 Yamanouchi Pharmaceut Co Ltd 塩酸ニカルジピンの注射剤およびその製法
USRE34618E (en) * 1984-05-22 1994-05-24 Yamanouchi Pharmaceutical Co., Ltd. Injection of nicardinpine hydrochloride and process for the production thereof
DE3423105A1 (de) * 1984-06-22 1986-01-02 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung optisch aktiver 1,4-dihydropyridine
JPS6143165A (ja) * 1984-08-07 1986-03-01 Otsuka Pharmaceut Co Ltd ジヒドロピリジン誘導体の製造法
DE3431152A1 (de) * 1984-08-24 1986-03-06 Cassella Ag, 6000 Frankfurt Verfahren zur herstellung optisch aktiver, substituierter 1,4-dihydropyridine und ihre verwendung als arzneimittel
US4975440A (en) * 1984-09-28 1990-12-04 Byk Gulden Lomberg Chemische Fabrik Gmbh Optically-active 1,4-dihydropyridine
DE3447169A1 (de) * 1984-12-22 1986-07-03 Bayer Ag, 5090 Leverkusen Optisch aktive nitrodihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln
JPS61161263A (ja) * 1985-01-09 1986-07-21 Teijin Ltd １，４−ジヒドロピリジンモノエステルモノカルボン酸の製造法
US4771057A (en) * 1986-02-03 1988-09-13 University Of Alberta Reduced pyridyl derivatives with cardiovascular regulating properties
DK142287A (da) * 1986-03-27 1987-09-28 Byk Gulden Lomberg Chem Fab Optisk aktive 1,4-dihydropyridinderivater
JPH0686429B2 (ja) * 1986-08-27 1994-11-02 株式会社ミドリ十字 ジヒドロピリジン誘導体
US4886819A (en) * 1986-08-27 1989-12-12 The Green Cross Corporation Dihydropyridine derivatives and pharmaceutical composition thereof
JPH0755955B2 (ja) * 1986-09-10 1995-06-14 日産化学工業株式会社 光学活性なジヒドロピリジン−５−ホスホン酸エステル
HU196755B (en) * 1986-09-16 1989-01-30 Gyogyszerkutato Intezet Process for production of new substituated amilid derivatives and medical compositions containing them
US4920225A (en) * 1986-12-22 1990-04-24 Laboratoires Syntex S.A. Resolution of 1,4-dihydropyridine derivatives
EP0353238A1 (de) * 1987-03-27 1990-02-07 Byk Gulden Lomberg Chemische Fabrik Gmbh Neue zwischenprodukte und verfahren
WO1988007525A1 (en) * 1987-03-27 1988-10-06 Byk Gulden Lomberg Chemische Fabrik Gmbh 1,4-dihydropyridine enantiomers
US4889866A (en) * 1987-06-11 1989-12-26 Syntex (U.S.A.) Inc. Arylsulfonyl dihydropyridine derivatives
JPS6429359A (en) * 1987-07-24 1989-01-31 Teijin Ltd 1,4-dihydropyridine derivative and production thereof
DE3821334A1 (de) * 1988-06-24 1989-12-28 Bayer Ag 1,4-dihydropyridin-threonin-derivate, verfahren zu ihrer herstellung, zwischenprodukte und ihre verwendung als arzneimittel
US5158963A (en) * 1989-08-02 1992-10-27 Kaken Pharmaceutical Co., Ltd. 1-4-dihydropyridine derivative, process for preparing the same and pharmaceutical composition containing the same
DE4011106A1 (de) * 1990-04-06 1991-10-10 Bayer Ag Neue heterocyclisch substituierte dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE4117750A1 (de) * 1991-05-30 1992-12-24 Bayer Ag Neue 2-amino-5-cyano-1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5834496A (en) * 1991-12-02 1998-11-10 Sepracor, Inc. Methods for treating hypertension using optically pure S(-) felodipine
AT399718B (de) * 1992-04-16 1995-07-25 Lek Tovarna Farmacevtskih Inklusionskomplexe von optisch aktiven und racemischen 1,4-dihydropyridinen mit methyl-beta- cyclodextrin oder anderen cyclodextrinderivaten, ein verfahren zur herstellung von optisch aktiven dihydropyridinen und deren inklusionskomplexen und diese komplexe enthaltende pharmazeutische formulierungen
DE4236707A1 (de) * 1992-10-30 1994-05-05 Bayer Ag 4-Heterocyclyl substituierte Dihydropyridine
ATE146788T1 (de) * 1992-10-30 1997-01-15 Bayer Ag 4-heterocyclophenyl substituierte dihydropyridine
US6001857A (en) * 1992-10-30 1999-12-14 Bayer Aktiengesellschaft Heterocyclyl substituted dihydropyridines
DE4342193A1 (de) * 1993-12-10 1995-06-14 Bayer Ag Arylsubstituierte Alkoxycarbonyl-1,4-dihydropyridin-5-carbonsäureester
EE03192B1 (et) * 1993-12-10 1999-06-15 Bayer Aktiengesellschaft Isopropüül-(2-metoksüetüül)-4-(2-kloro-3-tsüanofenüül)-1,4-dihüdro-2,6-dimetüülpüri diin-3,5-dikarboksülaat, selle enantiomeerid ja vaheühend, meetodid nimetatud ühendite valmistamiseks ja kasutamine
ATE234286T1 (de) 1993-12-10 2003-03-15 Bayer Ag Phenyl-substituierte 1,4-dihydropyridine mit cerebraler aktivität
US5478848A (en) * 1994-01-26 1995-12-26 Bayer Corporation Inhibition of arthritis by L-type calcium channel antagonists nimodipine, nisoldipine and nifedipine
DE19532320A1 (de) * 1995-09-01 1997-03-06 Bayer Ag Verfahren zur Herstellung von optisch aktiven ortho-substituierten 4-Aryl-Dihydropyridinen
JPH11106375A (ja) * 1997-08-18 1999-04-20 Pfizer Pharmaceut Inc ブラジキニンアンタゴニストとしての光学的に活性な１，４−ジヒドロピリジン化合物
US20100247646A1 (en) * 2009-03-26 2010-09-30 Ranbaxy Laboratories Limited Extended release tablets of nisoldipine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
US3985758A (en) * 1973-02-20 1976-10-12 Yamanouchi Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives
DE2508181A1 (de) * 1975-02-26 1976-09-09 Bayer Ag 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof
GB1591089A (en) * 1976-12-17 1981-06-10 Fujisawa Pharmaceutical Co 1,4-dihydropyridine derivatives and process for preparation thereof
SE429652B (sv) * 1978-06-30 1983-09-19 Haessle Ab 2.6-dimetyl-4-(2.3-diklorfenyl)-1.4-dihydropyridin-3.5-dikarboxylsyra-3-metylester-5-etylester
DE2935451A1 (de) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel

Also Published As

Publication number Publication date
DK241390A (da) 1990-10-05
JPH07600B2 (ja) 1995-01-11
PT71724B (en) 1981-06-17
DD154014A5 (de) 1982-02-17
DK164158C (da) 1992-10-12
DK241390D0 (da) 1990-10-05
CA1142937A (en) 1983-03-15
US4849433A (en) 1989-07-18
IE50504B1 (en) 1986-04-30
PT71724A (en) 1980-09-01
PL226503A1 (ja) 1982-05-24
NO159928C (no) 1989-02-22
IE801820L (en) 1981-03-01
DK164158B (da) 1992-05-18
AU6198280A (en) 1982-03-25
AR228576A1 (es) 1983-03-30
IL60937A0 (en) 1980-10-26
ZA805372B (en) 1981-09-30
EG15011A (en) 1985-03-31
DK160549C (da) 1991-09-16
NO802446L (no) 1981-03-02
FI78686B (fi) 1989-05-31
SU932988A3 (ru) 1982-05-30
US4510310A (en) 1985-04-09
EP0026317A1 (de) 1981-04-08
AU545023B2 (en) 1985-06-27
ES494614A0 (es) 1981-04-16
IL60937A (en) 1984-02-29
HU184821B (en) 1984-10-29
FI802717A (fi) 1981-03-02
PH17914A (en) 1985-01-25
GR70080B (ja) 1982-07-27
ES8104228A1 (es) 1981-04-16
JPS5636455A (en) 1981-04-09
NO159928B (no) 1988-11-14
NZ194805A (en) 1984-05-31
EP0026317B1 (de) 1985-10-16
DK160549B (da) 1991-03-25
JPH05310694A (ja) 1993-11-22
PL128310B1 (en) 1984-01-31
DK368480A (da) 1981-03-02
PH19749A (en) 1986-06-23
US4988717A (en) 1991-01-29
ATE16101T1 (de) 1985-11-15
DE2935451A1 (de) 1981-03-19
FI78686C (fi) 1989-09-11
PH19006A (en) 1985-12-03
DE3071186D1 (en) 1985-11-21

Similar Documents

Publication Publication Date Title
CS228506B2 (en) Method for the production of optical active ester of 1,4-dihydropyridincarboxyl acid
US4492703A (en) 4-(2-Substituted phenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid esters active on blood circulation
US4822798A (en) Circulation-active 4-phenyl-6-substituted dihydropyrimidines
FR2511247A1 (fr) Dihydropyridines ayant une action positivement inotrope, leur utilisation comme medicaments et un procede pour leur preparation
NO830612L (no) Nye forbindelser, fremgangsmaate til deres fremstilling samt deres anvendelse i legemidler
JPH0588226B2 (ja)
CZ396591A3 (en) Enantiomers of 1,4-dihydropyridine process of their preparation and pharmaceutical compositions prepared therefrom
US4772612A (en) Circulation-active 1,4-dihydropyridines
US4937242A (en) 1,4-dihydropyridine derivatives and pharmaceutical composition thereof
EP0197488A2 (en) 1,4-Dihydropyiridine derivative, a process for preparing the same, a pharmaceutical composition as well as the use thereof
US5464860A (en) N(pyrazol-3-yl) benzamides and pharmaceutical compositions
US4705786A (en) Novel oxadiazolyl-1,4-dihydropyridines useful as antihypertensive agents
JPS6256474A (ja) ジヒドロピリジン−２−ヒドロキシアミン類
EP0257616A2 (en) Dihydropyridine derivates and pharmaceutical composition thereof
IE922512A1 (en) Novel n-alkylated 1,4-dihydropyridinedicarboxylic acid¹esters
EP0093945A2 (en) 1,4-Dihydropyridine derivatives
US5064839A (en) 1,4-dihydropyridines with a 2-amino group or with an ether group in a side chain
EP0106276B1 (en) 1,4-dihydropyridine derivatives
US4886819A (en) Dihydropyridine derivatives and pharmaceutical composition thereof
NO893756L (no) Basiske 4-aryl-dhp-amider, fremgangsmaate til deres fremstilling og deres anvendelse i legemidler.
JP2640245B2 (ja) １，４−ジヒドロピリジン誘導体
US5158963A (en) 1-4-dihydropyridine derivative, process for preparing the same and pharmaceutical composition containing the same
US4593033A (en) Substituted indeno[2,1-c] pyridines useful as calcium channel blockers
HU197304B (en) Process for producing fluor-containing 1,4-dihydro-pyridines and pharmaceutical compositions containing them
EP0220917B1 (en) 1,4-dihydropyridine pharmaceutical derivatives and their salts, and the preparation thereof